Did Michael Saylor Just Back XRP Before March 7 Crypto Summit? Ripple’s $50M Initiative To Convert NormiesMarch 6, 2025
Market Trends Merck rival Summit draws new buy from Truist (SMMT:NASDAQ)By admin8996erT0allJanuary 8, 2025 narvikkSummit Therapeutics (NASDAQ:SMMT), a drug developer challenging pharma giant Merck’s (NYSE:MRK) dominance in lung cancer, won a new buy recommendation…
Market Trends Merck ends development of two antibody programsBy admin8996erT0allDecember 17, 2024 JHVEPhoto/iStock Editorial via Getty Images Merck (NYSE:MRK) is ceasing development of two monoclonal antibody candidates it was eying as fixed-doses…
